title: New insights on the role of hormonal therapy in ovarian cancer.
abstract: Ovarian cancer (OVCA) is the most lethal gynecological malignancy. It is often diagnosed in advanced stages and despite therapy, 70% relapse within 2years with incurable disease. Regimens with clinical benefit and minimal toxicity are urgently needed. More effective hormonal therapies would be appealing in this setting. Estrogens (E2) are implicated in the etiology of OVCA. Estrogens drive proliferation and anti-estrogens inhibit ovarian cancer growth in vitro and in vivo. Despite estrogen receptor (ER) expression in 67% of OVCAs, small anti-estrogen therapy trials have been disappointing and the benefit of hormonal therapy has not been systematically studied in large well-designed trials. OVCAs often manifest de novo anti-estrogen resistance and those that initially respond invariably develop resistance. Estrogens stimulate ovarian cancer progression by transcriptional activation and cross talk between liganded ER and mitogenic pathways, both of which drive cell cycle progression. Estrogen deprivation and estrogen receptor (ER) blockade cause cell cycle arrest in susceptible OVCAs by increasing the cell cycle inhibitor, p27. This review summarizes and discusses scientific and epidemiological evidence supporting estrogen's role in ovarian carcinogenesis, provides an overview of clinical trials of ER blockade and aromatase inhibitors in OVCA and reviews potential causes of antiestrogen resistance. Anti-estrogen resistance was recently shown to be reversed by dual ER and Src signaling blockade. Blocking cross-talk between ER and constitutively activated kinase pathways may improve anti-estrogen therapeutic efficacy in OVCA, as has been demonstrated in other cancers. Novel strategies to improve benefit from anti-estrogens by combining them with targeted therapies are reviewed.
authors: Division of Gynecology Oncology, University of Miami, Miller School of Medicine, Miami, FL, United States. fsimpkins@med.miami.edu
authors: Fiona
authors: F
authors: Simpkins
authors: Arlene
authors: A
authors: Garcia-Soto
authors: Joyce
authors: J
authors: Slingerland
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002453:Cell Cycle / Q000187:drug effects; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors / Q000235:genetics
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen
references: J Natl Cancer Inst. 2002 Apr 3;94(7):497-504
references: 11929950
references: Endocr Relat Cancer. 2005 Dec;12(4):851-66
references: 16322326
references: J Clin Endocrinol Metab. 1998 Mar;83(3):1025-8
references: 9506768
references: Clin Cancer Res. 2009 May 1;15(9):2971-8
references: 19383821
references: Mol Hum Reprod. 1998 Aug;4(8):811-5
references: 9733440
references: Annu Rev Biochem. 1994;63:451-86
references: 7979245
references: Mol Endocrinol. 2006 Aug;20(8):1707-14
references: 16396959
references: Cancer Lett. 2006 Jan 18;231(2):151-7
references: 16399219
references: J Biol Chem. 2001 Oct 5;276(40):36869-72
references: 11459850
references: Obstet Gynecol. 2000 Sep;96(3):417-21
references: 10960636
references: Endocrinology. 2001 Sep;142(9):4120-30
references: 11517191
references: J Steroid Biochem Mol Biol. 1998 Feb;64(3-4):137-45
references: 9605408
references: Mol Endocrinol. 2003 May;17(5):792-803
references: 12586845
references: Breast Cancer Res Treat. 2003 Jul;80(1):79-85
references: 12889601
references: J Biol Chem. 2002 Jul 5;277(27):24353-60
references: 11986316
references: J Biol Chem. 2005 Mar 25;280(12):11961-72
references: 15655247
references: J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):131-5
references: 8049141
references: Mod Pathol. 2011 Mar;24(3):453-62
references: 21102415
references: Lancet. 2007 May 19;369(9574):1703-10
references: 17512855
references: Endocrine. 2005 Apr;26(3):297-300
references: 16034185
references: Ginekol Pol. 1998 Jul;69(7):586-9
references: 9810419
references: Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):316-20
references: 8552629
references: J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):119-24
references: 11384869
references: J Clin Oncol. 1993 Oct;11(10):1957-68
references: 7691999
references: Obstet Gynecol. 1985 Oct;66(4):575-8
references: 4047546
references: Mol Interv. 2003 Aug;3(5):281-92
references: 14993442
references: Obstet Gynecol. 2008 Jan;111(1):144-51
references: 18165403
references: Gynecol Oncol. 1987 Jun;27(2):208-13
references: 3570058
references: Endocr Relat Cancer. 1999 Jun;6(2):197-204
references: 10731109
references: Gynecol Oncol. 2003 Jan;88(1):73-9
references: 12504632
references: J Endocrinol. 2007 Jun;193(3):421-33
references: 17535880
references: Gynecol Oncol. 2005 Oct;99(1):248-50
references: 16095676
references: Eur J Cancer. 2000 Sep;36 Suppl 4:S59-61
references: 11056321
references: Anticancer Res. 1996 Jan-Feb;16(1):91-7
references: 8615676
references: FEBS Lett. 2004 May 21;566(1-3):169-72
references: 15147889
references: Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9042-6
references: 10908655
references: Mol Cell Endocrinol. 1994 Feb;99(1):11-9
references: 8187952
references: Cancer Res. 2000 Jan 15;60(2):245-8
references: 10667568
references: Cancer Res. 2007 Feb 15;67(4):1859-66
references: 17308128
references: J Pharmacol Exp Ther. 2001 Sep;298(3):873-8
references: 11504779
references: Anticancer Res. 1995 Nov-Dec;15(6B):2639-42
references: 8669839
references: Cancer Res. 2004 Aug 15;64(16):5861-9
references: 15313930
references: Cancer Res. 2001 Mar 15;61(6):2537-41
references: 11289127
references: Oncol Rep. 2007 Nov;18(5):1051-9
references: 17914554
references: Clin Cancer Res. 2002 Jul;8(7):2233-9
references: 12114425
references: Cell. 2007 Jan 26;128(2):281-94
references: 17254967
references: Clin Adv Hematol Oncol. 2005 Sep;3(9):723-36
references: 16224447
references: Obstet Gynecol. 1982 May;59(5):583-8
references: 7070729
references: Cancer. 2009 Feb 1;115(3):531-9
references: 19127543
references: Cancer Res. 2005 Nov 15;65(22):10381-8
references: 16288028
references: Am J Obstet Gynecol. 2003 Jul;189(1):22-7
references: 12861133
references: Bull Acad Natl Med. 1999;183(5):955-68; discussion 968-71
references: 10465000
references: Cancer. 1989 Mar 15;63(6):1074-8
references: 2917311
references: Eur J Cancer Clin Oncol. 1986 Mar;22(3):309-12
references: 3709599
references: Gynecol Oncol. 2004 May;93(2):390-3
references: 15099951
references: Gynecol Oncol. 2009 May;113(2):205-9
references: 19239974
references: Cancer. 1991 Jul 15;68(2):269-71
references: 2070324
references: Mol Cell Biol. 1997 Jul;17(7):4059-69
references: 9199341
references: Breast Cancer Res Treat. 1995;36(3):267-85
references: 8573710
references: Int J Gynecol Cancer. 1995 Jul;5(4):301-305
references: 11578494
references: J Biol Chem. 2001 Nov 2;276(44):40888-95
references: 11527971
references: J Clin Endocrinol Metab. 2005 Jun;90(6):3688-95
references: 15755852
references: Gynecol Oncol. 2003 Dec;91(3):596-602
references: 14675683
references: Nucleic Acids Res. 2001 Jul 15;29(14):2905-19
references: 11452016
references: Carcinogenesis. 2011 Apr;32(4):589-96
references: 21173433
references: Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13162-7
references: 16938840
references: Proc Natl Acad Sci U S A. 1987 Dec;84(24):9243-7
references: 3321071
references: Clin Cancer Res. 2009 May 15;15(10):3396-405
references: 19451593
references: Ann N Y Acad Sci. 1995 Dec 29;774:16-28
references: 8597456
references: J Steroid Biochem Mol Biol. 2005 Jan;93(1):15-24
references: 15748828
references: Gynecol Oncol. 2010 Dec;119(3):444-50
references: 20846715
references: Breast Cancer Res Treat. 2011 Jul;128(1):69-78
references: 20669046
references: J Pathol. 2003 Oct;201(2):213-20
references: 14517838
references: Cancer Cell. 2004 Sep;6(3):209-14
references: 15380511
references: Med Oncol. 2007;24(1):39-43
references: 17673810
references: Am J Surg Pathol. 2001 May;25(5):667-72
references: 11342781
references: Prostate. 2003 Feb 1;54(2):79-87
references: 12497580
references: Curr Treat Options Oncol. 2002 Apr;3(2):131-41
references: 12057076
references: Cancer Res. 1988 Nov 15;48(22):6491-7
references: 3180066
references: Clin Cancer Res. 2012 Nov 1;18(21):5911-23
references: 22896656
references: Endocr Relat Cancer. 2000 Jun;7(2):85-93
references: 10903526
references: Br J Cancer. 1988 Jan;57(1):115-6
references: 3348944
references: Gynecol Oncol. 2011 Sep;122(3):573-9
references: 21665249
references: Gynecol Oncol. 2008 Jul;110(1):56-9
references: 18457865
references: Clin Cancer Res. 2007 Jun 15;13(12):3617-22
references: 17575226
references: Am J Pathol. 2004 Jun;164(6):2003-12
references: 15161636
references: Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):865s-70s
references: 15701879
references: Mol Cancer Ther. 2007 Jan;6(1):93-100
references: 17237269
references: Cancer Sci. 2008 Dec;99(12):2365-72
references: 19032364
references: J Surg Oncol. 2006 May 1;93(6):504-10
references: 16615154
references: Mol Cell Endocrinol. 2004 Jun 30;221(1-2):97-104
references: 15223136
references: JAMA. 2001 Mar 21;285(11):1460-5
references: 11255422
references: Gynecol Oncol. 1997 Feb;64(2):189-95
references: 9038263
references: Cancer Res. 2003 Jun 1;63(11):2820-8
references: 12782587
references: Endocr Rev. 1999 Jun;20(3):253-78
references: 10368771
references: Acta Oncol. 1995;34(6):813-20
references: 7576750
references: Br J Cancer. 2004 Jan 12;90(1):20-5
references: 14710200
references: Oncology. 2004;66(2):112-7
references: 15138362
references: Cancer Res. 1998 Dec 1;58(23):5367-73
references: 9850067
references: Arch Intern Med. 2004 Nov 8;164(20):2253-9
references: 15534163
references: Clin Cancer Res. 2004 Sep 1;10(17):5769-76
references: 15355905
references: Gynecol Oncol. 1989 Apr;33(1):76-81
references: 2703171
references: Eur J Cancer. 1994;30A(5):682-6
references: 8080688
references: Oncogene. 2002 Feb 7;21(7):1097-107
references: 11850827
references: Oncogene. 2003 Oct 23;22(48):7600-6
references: 14576822
references: JAMA. 2002 Jul 17;288(3):334-41
references: 12117398